Resolution of oligomeric species during the aggregation of Aβ1-40 using 19F NMR

Biochemistry

Volumn 52, Issue 11, 2013, Pages 1903-1912

  Suzuki, Yuta ^a   Brender, Jeffrey R ^a   Soper, Molly T ^a   Krishnamoorthy, Janarthanan ^a   Zhou, Yunlong ^a   Ruotolo, Brandon T ^a   Kotov, Nicholas A ^a   Ramamoorthy, Ayyalusamy ^a   Marsh, E Neil G ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOGENIC PROTEINS; COMPLEX MECHANISMS; CRITICAL VALUE; FIBER FORMATION; LAG PHASE; PROTEIN AGGREGATION; REVERSIBLE FORMATION; SPECTROSCOPIC TECHNIQUE;

PROTEINS;

OLIGOMERS;

AMYLOID BETA PROTEIN[1-40]; AMYLOID PROTEIN; OLIGOMER;

ARTICLE; ATOMIC FORCE MICROSCOPY; CIRCULAR DICHROISM; ELECTROSPRAY MASS SPECTROMETRY; FLUORINE NUCLEAR MAGNETIC RESONANCE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN AGGREGATION; SOLUBILIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CIRCULAR DICHROISM; HUMANS; METHIONINE; MICROSCOPY, ATOMIC FORCE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; SOLUBILITY;

EID: 84875459494     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi400027y     Document Type: Article

References (68)

1. Harrison, R. S., Sharpe, P. C., Singh, Y., and Fairlie, D. P. (2007) Amyloid peptides and proteins in review Rev. Physiol. Biochem. Pharmacol. 159, 1-77
2. Fandrich, M. (2007) On the structural definition of amyloid fibrils and other polypeptide aggregates Cell. Mol. Life Sci. 64, 2066-2078
3. Jahn, T. R., Makin, O. S., Morris, K. L., Marshall, K. E., Tian, P., Sikorski, P., and Serpell, L. C. (2010) The common architecture of cross-β amyloid J. Mol. Biol. 395, 717-727
4. Hamley, I. W. (2012) The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization Chem. Rev. 112, 5147-5192
5. Hardy, J. A. and Higgins, G. A. (1992) Alzheimer's Disease-the amyloid cascade hypothesis Science 256, 184-185
6. Hardy, J. (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal J. Neurochem. 110, 1129-1134
7. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics Science 297, 353-356
8. Pryor, N. E., Moss, M. A., and Hestekin, C. N. (2012) Unraveling the early events of amyloid-beta protein (Aβ) aggregation: Techniques for the determination of Aβ aggregate size Int. J. Mol. Sci. 13, 3038-3072
9. Mishra, R., Geyer, M., and Winter, R. (2009) NMR spectroscopic investigation of early events in IAPP amyloid fibril formation ChemBioChem 10, 1769-1772
10. Yan, Y. L. and Wang, C. Y. (2006) Aβ42 is more rigid than Aβ40 at the C-terminus: Implications for Aβ aggregation and toxicity J. Mol. Biol. 364, 853-862
11. Kitevski-LeBlanc, J. L. and Prosser, R. S. (2012) Current applications of F-19 NMR to studies of protein structure and dynamics Prog. Nucl. Magn. Reson. Spectrosc. 62, 1-33
12. Li, H. and Frieden, C. (2007) Comparison of C40/82A and P27A C40/82A barstar mutants using F-19 NMR Biochemistry 46, 4337-4347
13. Li, H. L. and Frieden, C. (2007) Observation of sequential steps in the folding of intestinal fatty acid binding protein using a slow folding mutant and F-19 NMR Proc. Natl. Acad. Sci. U.S.A. 104, 11993-11998
14. Li, H. and Frieden, C. (2006) Fluorine-19 NMR studies on the acid state of the intestinal fatty acid binding protein Biochemistry 45, 6272-6278
15. Li, H. and Frieden, C. (2005) NMR studies of 4-F-19-phenylalanine-labeled intestinal fatty acid binding protein: Evidence for conformational heterogeneity in the native state Biochemistry 44, 2369-2377
16. 19F NMR spectroscopy ChemBioChem 11, 1993-1996
17. 19F NMR studies of α-synuclein-membrane interactions Protein Sci. 19, 1686-1691
18. 19F NMR applications in chemical biology J. Fluorine Chem. 130, 132-143
19. 19F NMR in Escherichia coli J. Am. Chem. Soc. 132, 321-327
20. 19F nuclear magnetic resonance-detected kinetics of monomer consumption Biochemistry 51, 8154-8162
21. Soong, R., Brender, J. R., Macdonald, P. M., and Ramamoorthy, A. (2009) Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy J. Am. Chem. Soc. 131, 7079-7085
22. Vaiana, S. M., Ghirlando, R., Yau, W. M., Eaton, W. A., and Hofrichter, J. (2008) Sedimentation studies on human amylin fail to detect low-molecular-weight oligomers Biophys. J. 94, L45-L47
23. Marek, P., Mukherjee, S., Zanni, M. T., and Raleigh, D. P. (2010) Residue-specific, real-time characterization of lag-phase species and fibril growth during amyloid formation: A combined fluorescence and IR Study of p-cyanophenylalanine analogs of islet amyloid polypeptide J. Mol. Biol. 400, 878-888
24. Lee, J., Culyba, E. K., Powers, E. T., and Kelly, J. W. (2011) Amyloid-β forms fibrils by nucleated conformational conversion of oligomers Nat. Chem. Biol. 7, 602-609
25. Benilova, I., Karran, E., and De Strooper, B. (2012) The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes Nat. Neurosci. 15, 349-357
26. Miller, Y., Ma, B., and Nussinov, R. (2010) Polymorphism in Alzheimer Aβ Amyloid organization reflects conformational selection in a rugged energy landscape Chem. Rev. 110, 4820-4838
27. Ma, B. Y. and Nussinov, R. (2012) Selective molecular recognition in amyloid growth and transmission and cross-species barriers J. Mol. Biol. 421, 172-184
28. Jiang, L. and Burgess, K. (2002) Fluorinated and iodinated templates for syntheses of β-turn peptidomimetics Tetrahedron 58, 8743-8750
29. 19F NMR Biochemistry 36, 3404-3416
30. Kieltsch, I., Eisenberger, P., and Togni, A. (2007) Mild electrophilic trifluoromethylation of carbon- and sulfur-centered nucleophiles by a hypervalent iodine(III)-CF3 reagent Angew. Chem., Int. Ed. 46, 754-757
31. Garner, D. K., Vaughan, M. D., Hwang, H. J., Savelieff, M. G., Berry, S. M., Honek, J. F., and Lu, Y. (2006) Reduction potential tuning of the blue copper center in Pseudomonas aeruginosa azurin by the axial methionine as probed by unnatural amino acids J. Am. Chem. Soc. 128, 15608-15617
32. Pelta, M. D., Barjat, H., Morris, G. A., Davis, A. L., and Hammond, S. J. (1998) Pulse sequences for high-resolution diffusion-ordered spectroscopy (HR-DOSY) Magn. Reson. Chem. 36, 706-714
33. Stejskal, E. O. and Tanner, J. E. (1965) Spin diffusion measurements: Spin Echoes in the presence of a time-dependent field gradient J. Chem. Phys. 42, 288-292
34. Hernández, H. and Robinson, C. V. (2007) Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry Nat. Protoc. 2, 715-726
35. Fawzi, N. L., Ying, J., Torchia, D. A., and Clore, G. M. (2010) Kinetics of amyloid βmonomer-to-oligomer exchange by NMR relaxation J. Am. Chem. Soc. 132, 9948-9951
36. Fawzi, N. L., Ying, J. F., Ghirlando, R., Torchia, D. A., and Clore, G. M. (2011) Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR Nature 480, 268-272
37. Pedersen, M. O., Mikkelsen, K., Behrens, M. A., Pedersen, J. S., Enghild, J. J., Skrydstrup, T., Malmendal, A., and Nielsen, N. C. (2010) NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates J. Phys. Chem. B 114, 16003-16010
38. Nag, S., Sarkar, B., Bandyopadhyay, A., Sahoo, B., Sreenivasan, V. K. A., Kombrabail, M., Muralidharan, C., and Maiti, S. (2011) Nature of the amyloid-β monomer and the monomer-oligomer equilibrium J. Biol. Chem. 286, 13827-13833
39. Krishnamoorthy, J., Brender, J. R., Vivekanandan, S., Jahr, N., and Ramamoorthy, A. (2012) Side-chain dynamics reveals transient association of Aβ(1-40) monomers with amyloid fibers J. Phys. Chem. B 116, 13618-13623
40. Narayanan, S. and Reif, B. (2005) Characterization of chemical exchange between soluble and aggregated states of β-amyloid by solution-state NMR upon variation of salt conditions Biochemistry 44, 1444-1452
41. Ono, K., Condron, M. M., and Teplow, D. B. (2009) Structure-neurotoxicity relationships of amyloid beta-protein oligomers Proc. Natl. Acad. Sci. U.S.A. 106, 14745-14750
42. Bernstein, S. L., Dupuis, N. F., Lazo, N. D., Wyttenbach, T., Condron, M. M., Bitan, G., Teplow, D. B., Shea, J. E., Ruotolo, B. T., Robinson, C. V., and Bowers, M. T. (2009) Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease Nat. Chem. 1, 326-331
43. Landau, M., Sawaya, M. R., Faull, K. F., Laganowsky, A., Jiang, L., Sievers, S. A., Liu, J., Barrio, J. R., and Eisenberg, D. (2011) Towards a Pharmacophore for Amyloid PLoS Biol. 9, e1001080
44. del Amo, J. M. L., Fink, U., Dasari, M., Grelle, G., Wanker, E. E., Bieschke, J., and Reif, B. (2012) Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers J. Mol. Biol. 421, 517-524
45. Paravastu, A. K., Leapman, R. D., Yau, W. M., and Tycko, R. (2008) Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils Proc. Natl. Acad. Sci. U.S.A. 105, 18349-18354
46. Tycko, R. (2011) Solid-State NMR Studies of Amyloid Fibril Structure Annu. Rev. Phys. Chem. 62, 279-299
47. Stroud, J. C., Liu, C., Teng, P. K., and Eisenberg, D. (2012) Toxic fibrillar oligomers of amyloid-β have cross-β structure Proc. Natl. Acad. Sci. U.S.A. 109, 7717-7722
48. Fandrich, M. (2012) Oligomeric intermediates in amyloid formation: Structure determination and mechanisms of toxicity J. Mol. Biol. 421, 427-440
49. Scheidt, H. A., Morgado, I., and Huster, D. (2012) Solid-state NMR reveals a close structural relationship between amyloid-β protofibrils and oligomers J. Biol. Chem. 287, 22822-22826
50. Chimon, S., Shaibat, M. A., Jones, C. R., Calero, D. C., Aizezi, B., and Ishii, Y. (2007) Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid Nat. Struct. Mol. Biol. 14, 1157-1164
51. Rosensweig, C., Ono, K., Murakami, K., Lowenstein, D. K., Bitan, G., and Teplow, D. B. (2012) Preparation of Stable Amyloid beta-Protein Oligomers of Defined Assembly Order Methods Mol. Biol. 849, 23-31
52. Yu, L. P., Edalji, R., Harlan, J. E., Holzman, T. F., Lopez, A. P., Labkovsky, B., Hillen, H., Barghorn, S., Ebert, U., Richardson, P. L., Miesbauer, L., Solomon, L., Bartley, D., Walter, K., Johnson, R. W., Hajduk, P. J., and Olejniczak, E. T. (2009) Structural characterization of a soluble amyloid β-peptide oligomer Biochemistry 48, 1870-1877
53. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ(1-42) are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
54. Yamaguchi, T., Yagi, H., Goto, Y., Matsuzaki, K., and Hoshino, M. A Disulfide-Linked Amyloid-β peptide dimer forms a protofibril-like oligomer through a distinct pathway from amyloid fibril formation, Biochemistry 49, 7100-7107.
55. Cohen, S. I. A., Vendruscolo, M., Dobson, C. M., and Knowles, T. P. J. (2012) From macroscopic measurements to microscopic mechanisms of protein aggregation J. Mol. Biol. 421, 160-171
56. Morris, A. M., Watzky, M. A., and Finke, R. G. (2009) Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature Biochim. Biophys. Acta 1794, 375-397
57. Liang, Y., Lynn, D. G., and Berland, K. M. (2010) Direct observation of nucleation and growth in amyloid self-assembly J. Am. Chem. Soc. 132, 6306-6308
58. Ban, T., Yamaguchi, K., and Goto, Y. (2006) Direct observation of amyloid fibril growth, propagation, and adaptation Acc. Chem. Res. 39, 663-670
59. Knowles, T. P. J., White, D. A., Abate, A. R., Agresti, J. J., Cohen, S. I. A., Sperling, R. A., De Genst, E. J., Dobson, C. M., and Weitz, D. A. (2011) Observation of spatial propagation of amyloid assembly from single nuclei Proc. Natl. Acad. Sci. U.S.A. 108, 14746-14751
60. Alexandrescu, A. T. (2005) Amyloid accomplices and enforcers Protein Sci. 14, 1-12
61. Kuo, Y. M., Emmerling, M. R., Lampert, H. C., Hempelman, S. R., Kokjohn, T. A., Woods, A. S., Cotter, R. J., and Roher, A. E. (1999) High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer's disease Biochem. Biophys. Res. Commun. 257, 787-791
62. Hoozemans, J. J. M., Chafekar, S. M., Baas, F., Eikelenboom, P., and Scheper, W. (2006) Always around, never the same: Pathways of amyloid β induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease Curr. Med. Chem. 13, 2599-2605
63. O'Nuallain, B., Shivaprasad, S., Kheterpal, I., and Wetzel, R. (2005) Thermodynamics of Aβ(1-40) amyloid fibril elongation Biochemistry 44, 12709-12718
64. Huang, T. H. J., Yang, D. S., Fraser, P. E., and Chakrabartty, A. (2000) Alternate aggregation pathways of the Alzheimer β-amyloid peptide-An in vitro model of preamyloid J. Biol. Chem. 275, 36436-36440
65. Friedrich, R. P., Tepper, K., Roznicke, R., Soom, M., Westermann, M., Reymann, K., Kaether, C., and Fandrich, M. (2010) Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity Proc. Natl. Acad. Sci. U.S.A. 107, 1942-1947
66. Hu, X. Y., Crick, S. L., Bu, G. J., Frieden, C., Pappu, R. V., and Lee, J. M. (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-β peptide Proc. Natl. Acad. Sci. U.S.A. 106, 20324-20329
67. Pronchik, J., He, X. L., Giurleo, J. T., and Talaga, D. S. (2010) In vitro formation of amyloid from α-synuclein is dominated by reactions at hydrophobic interfaces J. Am. Chem. Soc. 132, 9797-9803
68. Petkova, A. T., Leapman, R. D., Guo, Z. H., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils Science 307, 262-265